Mammalian animal composition
AssigneeMars, Incorporated
InventorsMarie-Louise Amanda Baillon, Richard Fulton Butterwick
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of probiotic microorganism in the manufacture of a composition for the prevention or reduction of gastrointestinal Campylobacter infection in a mammalian animal. It also relates to a method for the prevention or reduction of gastrointestinal Campylobacter infection in a mammalian animal, the method comprising administering to said animal, a probiotic microorganism. The invention also relates to a probiotic microorganism, for use in preventing or reducing gastrointestinal Campylobacter infection in a mammalian animal.
Claims6
A biologically pure culture of a probiotic microorganism, for use in preventing or reducing gastrointestinal Campylobacter infection in a mammalian animal, wherein the probiotic microorganism is Lactobacillus acidophilus having accession number NCIMB 41117.
A method for the prevention or reduction of gastrointestinal Campylobacter infection in a mammalian animal, the method comprising feeding said animal a foodstuff having an effective amount of a probiotic microorganism, wherein the probiotic microorganism is Lactobacillus acidophilus having accession number NCIMB 41117.
Dependencies are inferred from the claim text.